Biovie Inc Stock Performance

BIVI Stock  USD 1.08  0.06  5.88%   
The firm shows a Beta (market volatility) of 2.12, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Biovie will likely underperform. At this point, Biovie Inc has a negative expected return of -1.23%. Please make sure to confirm Biovie's potential upside, as well as the relationship between the rate of daily change and period momentum indicator , to decide if Biovie Inc performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Biovie Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders. ...more
Last Split Factor
1:10
Dividend Date
2019-11-22
Last Split Date
2024-08-06
1
Acquisition by Do Cuong V of 104502 shares of Biovie at 1.9 subject to Rule 16b-3
12/20/2024
2
Acquisition by Rogich Sigmund of 123400 shares of Biovie at 5.04 subject to Rule 16b-3
12/27/2024
3
BioVie Inc. Joins Forces With New to The Street for a Dynamic 6-Part Media Campaign Featuring Long-Form Interviews, National TV Commercials, Iconic Billboards, ...
01/13/2025
4
Is BioVie In A Good Position To Invest In Growth
02/13/2025
5
Biovie stock plunges to 52-week low, touches 1.04 - Investing.com
03/11/2025
Begin Period Cash Flow19.5 M
  

Biovie Relative Risk vs. Return Landscape

If you would invest  249.00  in Biovie Inc on December 17, 2024 and sell it today you would lose (141.00) from holding Biovie Inc or give up 56.63% of portfolio value over 90 days. Biovie Inc is currently does not generate positive expected returns and assumes 5.5714% risk (volatility on return distribution) over the 90 days horizon. In different words, 49% of stocks are less volatile than Biovie, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Biovie is expected to under-perform the market. In addition to that, the company is 6.19 times more volatile than its market benchmark. It trades about -0.22 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly -0.08 per unit of volatility.

Biovie Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Biovie's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Biovie Inc, and traders can use it to determine the average amount a Biovie's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.2209

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsBIVI

Estimated Market Risk

 5.57
  actual daily
49
51% of assets are more volatile

Expected Return

 -1.23
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.22
  actual daily
0
Most of other assets perform better
Based on monthly moving average Biovie is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Biovie by adding Biovie to a well-diversified portfolio.

Biovie Fundamentals Growth

Biovie Stock prices reflect investors' perceptions of the future prospects and financial health of Biovie, and Biovie fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Biovie Stock performance.

About Biovie Performance

By evaluating Biovie's fundamental ratios, stakeholders can gain valuable insights into Biovie's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Biovie has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Biovie has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Return On Tangible Assets(1.18)(1.24)
Return On Capital Employed(2.33)(2.45)
Return On Assets(1.47)(1.54)
Return On Equity(2.38)(2.50)

Things to note about Biovie Inc performance evaluation

Checking the ongoing alerts about Biovie for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Biovie Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Biovie Inc generated a negative expected return over the last 90 days
Biovie Inc has high historical volatility and very poor performance
Biovie Inc has some characteristics of a very speculative penny stock
Biovie Inc has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (32.12 M) with profit before overhead, payroll, taxes, and interest of 0.
Biovie Inc currently holds about 18.64 M in cash with (27.95 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.62.
Biovie Inc has a frail financial position based on the latest SEC disclosures
Roughly 13.0% of the company shares are held by company insiders
Latest headline from news.google.com: Biovie stock plunges to 52-week low, touches 1.04 - Investing.com
Evaluating Biovie's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Biovie's stock performance include:
  • Analyzing Biovie's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Biovie's stock is overvalued or undervalued compared to its peers.
  • Examining Biovie's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Biovie's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Biovie's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Biovie's stock. These opinions can provide insight into Biovie's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Biovie's stock performance is not an exact science, and many factors can impact Biovie's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Biovie Stock analysis

When running Biovie's price analysis, check to measure Biovie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biovie is operating at the current time. Most of Biovie's value examination focuses on studying past and present price action to predict the probability of Biovie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biovie's price. Additionally, you may evaluate how the addition of Biovie to your portfolios can decrease your overall portfolio volatility.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity